JAZZ - Jazz Pharmaceuticals beats Q2 estimates narrows FY revenue guidance
2024-07-31 16:10:10 ET
More on Jazz Pharmaceuticals
- Jazz Pharmaceuticals: Pipeline Setback While Business Transition Continues
- Jazz Pharmaceuticals Q2 2024 Earnings Preview
- Jazz Pharma slips as mid-stage trial for neuro candidate fails
- Seeking Alpha’s Quant Rating on Jazz Pharmaceuticals
- Historical earnings data for Jazz Pharmaceuticals